Assessment of Food Effect and pH‐Dependent Drug–Drug Interactions of Fruquintinib in Healthy Subjects
ABSTRACT This two‐sequence, three‐period study (NCT04645940) was designed to evaluate the effect of food and concomitant rabeprazole, a proton pump inhibitor, on the pharmacokinetics (PK) and safety of fruquintinib and its metabolite M11 after a single oral dose of fruquintinib 5 mg in healthy subje...
Saved in:
| Main Authors: | Martha Gonzalez, Zhao Yang, William R. Schelman, Xiaofei Zhou, Neeraj Gupta, Caly Chien |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Clinical and Translational Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/cts.70168 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of clinical and pharmacodynamic features of proton pump inhibitors efficacy in gastroesophageal reflux disease
by: O. A. Storonova, et al.
Published: (2015-12-01) -
The choice of proton pump inhibitor from the standpoint of efficacy and safety in a particular patient
by: E. A. Lyalukova, et al.
Published: (2021-06-01) -
Clinical Progress of Fruquintinib in Colorectal Cancer: An Overview
by: Yejie Xie, et al.
Published: (2025-02-01) -
Current Trends in Treatment for Acid-Dependent Diseases: Clinical Efficacy and Safety of Rabeprazole
by: O. D. Lopina, et al.
Published: (2021-12-01) -
Case Report: Fruquintinib-induced hyperbilirubinemia: a rare cause of dialyzer filter discoloration in a patient undergoing long-term dialysis
by: Mercedes Galloway, et al.
Published: (2025-07-01)